Electrochemical separation is an attractive strategy for development of radionuclide generators for medical applications

Current Radiopharmaceuticals

Volumn 5, Issue 3, 2012, Pages 271-287

  Chakravarty, Rubel ^a   Dash, Ashutosh ^a   Pillai, M R A ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Electrochemical separation; No carrier added; Radionuclide generator

Indexed keywords

ELECTROLYTE; GOLD; HYDROGEN; IONIC LIQUID; MOLYBDENUM 99; PLATINUM; PROTON; RADIOISOTOPE; RHENIUM 188; STRONTIUM 90; TECHNETIUM 99M; TUNGSTEN; WATER; YTTRIUM 90;

ADSORPTION CHROMATOGRAPHY; ARTICLE; BONE PAIN; BRACHYTHERAPY; CANCER RADIOTHERAPY; COLUMN CHROMATOGRAPHY; ELECTROCHEMICAL ANALYSIS; ELECTROCHEMISTRY; ELECTRODE; ELECTROLYSIS; HUMAN; ION EXCHANGE; ISOTOPE LABELING; LIVER CANCER; METHODOLOGY; PAPER CHROMATOGRAPHY; PERFORMANCE; PH; PRIORITY JOURNAL; QUALITY CONTROL; RADIOCHEMISTRY; RADIOIMMUNOTHERAPY; RADIOLYSIS; RESTENOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN CANCER; SOLVENT EXTRACTION; SYNOVECTOMY; SYNOVIORTHESIS; TEMPERATURE;

EID: 84863547206     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011205030271     Document Type: Article

References (144)

1. 90Y suitable for targeted therapy. Nucl. Med. Biol., 2008, 35, 245-252.
2. 188Re electrochemical generator with potential for medical applications. Radiochim. Acta, 2009, 97, 309-317.
3. 99Mo. Nucl. Med. Biol., 2010, 37, 421-428.
4. 99mTc generator. J. Radioanal. Nucl. Chem., 2011, 290, 45-51.
5. Rosch, F.; Knapp Jr., F. F. Radionuclide generators. In: Handbook of Nuclear Chemistry, Vertes, A.; Nagy, S.; Klenscar, Z.; Ed.; Kluwer Academic Publisher: Dordrecht, The Netherlands, 2003; pp 81-118.
6. Rösch, F.; Knapp, F. F. Radionuclide generators. In: Handbook of radionuclide generators, Springer: The Netherlands, 2011, pp 1935-1976. (DOI: 10.1007/978-1-4419-0720-2_40)
7. Knapp Jr., F. F.; Mirzadeh S. The continuing important role of radionuclide generator systems for nuclear medicine. Eur. J. Nucl. Med., 1994, 21, 1151-1165.
8. Mirzadeh, S.; Knapp Jr., F. F. Biomedical radioisotope generator systems. J. Radioanal. Nucl. Chem., 1996, 203, 471-488.
9. Richards, P. Radionuclide generators. In: Radioactive pharmaceuticals, Andrews G. A., Ed.; U.S. A.E.C. Symposium Series: Oak-Ridge, Tennessee, USA, 1965; pp 155-163.
10. Knapp Jr., F.F.; Butler, T.A. (Ed.). Radionuclide generators: New systems for nuclear medicine applications. ACS Symposium Series, American Chemical Society, USA, 1984.
11. Eckelman, W.C. Unparalleled contribution of technetium-99m to medicine over 5 decades, J. Am. Coll. Cardiol. Img. 2009, 2, 364-368.
12. Boyd, R.E. Technetium-99m generators-The available options. Int. J. Appl. Radiat. Isot., 1982, 33, 801-809.
13. Boyd, R.E. Molybdenum-99: Technetium-99m generator. Radiochim. Acta 1982, 30, 123-145.
14. 99mTc generator technology. Int. J. Appl. Radiat. Isot. 1982, 33, 811-819.
15. Boyd, R.E. Technetium generators: Status and prospects. Radiochim Acta, 1987, 41, 59-63.
16. 99mTc-generator technologies. Radiochim. Acta, 1987, 41, 83-89.
17. 99mTc sublimation generators. Radiochim. Acta 1987, 41, 91-96.
18. 99mTc for nuclear medicine. Appl. Radiat. Isot., 1997, 48, 1027-1033.
19. Evans, J.V.; Moore, P.W.; Shying, M.E.; Sodeau, J.M. Zirconium molybdate gel as a generator for technetium-99m-I. The concept and its evaluation. Appl. Radiat. Isot., 1987, 38, 19-23.
20. Moore, P.W.; Shying, M.E.; Sodeau, J.M.; Evans, J.V.; Maddalena, D.J.; Farrington, K.H. Zirconium molybdate gel as a generator for technetium-99m-II. High activity generators. Appl. Radiat. Isot., 1987, 38, 25-29.
21. 188Re gel generator using tungsten of natural isotope abundance. Appl. Radiat. Isot., 2002, 57, 641-646.
22. 99mTc generators. J. Nucl. Radiochem. Sci., 2007, 8, 11-19.
23. 68Ga radiopharmaceutical chemistry. Curr. Top. Med. Chem., 2010, 10, 1633-1668.
24. Mushtaq, A. Inorganic ion-exchangers: Their role in chromatographic radionuclide generators for the decade 1993-2002. J. Radioanal. Nucl. Chem., 2004, 262, 797-810.
25. Knapp Jr., F.F.; Beets, A.L.; Mirzadeh, S.; Guhlke, S. Use of a new tandem cation/anion exchange system with clinical-scale generators provides high specific volume solutions of technetium-99m and rhenium-188. IAEA-TECDOC, 1998, 1029, 419-425.
26. 99Mo. Appl. Radiat. Isot. 1997, 48, 607-611.
27. 188Re generator. J. Nucl. Radiochem. Sci. 2005, 6, 189-191
28. Iller, E.; Deptula, A.; Brykala, M.; Sypula, M.; Konior, M. Preliminary results of synthesis and investigations of new materials for packing of chromatographic columns of W-188/Re-188 generators. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, S210.
29. 188Re Generators. IAEA-TRS-470, International Atomic Energy Agency, Vienna, 2009; pp 161-174.
30. Iller, E.; Polkowska-Motrenko, H.; Lada, W.; Wawszczak, D.; Sypula, M.; Doner, K.; Konior, M.; Milczarek, J.; Zoladek, J.; Ralis, J. Studies of gel metal-oxide composite samples as filling materials for W-188/Re-188 generator column. J. Radioanal. Nucl. Chem., 2009, 281, 83-86.
31. 188Re generator by using a synthetic alumina. Appl. Radiat. Isot. 2009, 67, 1162-1166.
32. 188Re nuclide pair separation. Sep. Sci. Technol., 2009, 44, 1074-1098.
33. Lee J.S., Han, H. S.; Park, U. J.; Son, K. J.; Shin, H. Y.; Hong, S. B.; Jang, K. D.; Lee, J. S. Adsorbents for radioisotopes, preparation method thereof, and radioisotope generators using the same. U.S. Patent 2010/0248955, September 30, 2010.
34. 99mTc generator, J. Nanosci. Nanotechnol., 2008, 8, 4447-4452.
35. 188W using polymer embedded nanocrystalline titania. Chromatographia 2009, 69, 1363-1371.
36. 188Re generator. Appl. Radiat. Isot., 2010, 68, 229-238.
37. 99mTc generator for biomedical applications. Chromatographia, 2010, 72, 875-884.
38. 68Ga generator. ACS Appl. Mater. Interfaces, 2010, 2, 2069-2075.
39. 68Ga generator for biomedical applications. Nucl. Med. Biol., 2011, 38, 575-583.
40. 188Re generator technology. Anal. Chem., 2011, 83, 6342-6348.
41. 99mTc generator using alumina microspheres for industrial radiotracer applications. Appl. Radiat. Isot., 2012, 70, 51-58.
42. 188Re by an electrochemical method. Appl. Radiat. Isot., 2010, 68, 2302-2305.
43. 177Lu from neutron irradiated Yb for biomedical applications. Nucl. Med. Biol., 2010, 37, 811-820.
44. 175Yb suitable for radiopharmaceutical applications. Radiochim. Acta (In press)
45. 99Mo]molybdate gel generator. Appl. Radiat. Isot. 2012, 70, 375-379.
46. nd Ed.; Wiley and Sons: New York, 2006.
47. st Ed.; Wiley and Sons: New York, 2000.
48. rd Ed.; Interscience Publishers, Inc.: New York, 1966.
49. Clarke, B.A.; Wooten, L. A.; Luke, C. L. Analysis by "internal" electrolysis. Ind. Eng. Chem. Anal. Ed., 1936, 8, 411-414.
50. Cyclotron produced radionuclides: Principles and practice. IAEA Technical Report Series No. 465, International Atomic Energy Agency, Vienna, 2008.
51. Cyclotron produced radionuclides: Physical characteristics and production methods. IAEA Technical Report Series No. 468, International Atomic Energy Agency, Vienna, 2009.
52. Morley, T.; Gagnon, K.; Schaffer, P.; Asselin, E.; Zeisler, S.; McQuarrie, S.; Kovacs, M.; Wilson, J.; Benard, F.; Ruth T. Cyclotron production of technetium radioisotopes. J. Nucl. Med., 2011, 52(S1), 291.
53. 86Y based on electrochemical separation. Appl. Radiat. Isot. 2009, 67, 523-529.
54. 68Ga generator with binary Ga/Ag electrodeposition as the solid target. J. Radioanal. Nucl. Chem. 2000, 245, 25-30.
55. 64Cu. J. Radioanal. Nucl. Chem. 2010, 286, 665-670.
56. Garrison, W.M.; Hamilton, J.G. Production and isolation of carrier-free radioisotopes. Chem. Rev., 1951, 49, 237-272.
57. Lange, G.; Herrmann, G.; Strassmann, F. Preparation of strontium-90-free yttrium-90 by electrolysis [in German]. J. Inorg. Nucl. Chem., 1957, 4,146-54.
58. Hamaguchi, H.; Ikeda, N.; Kawashima, T. Isolation of carrier free yttrium from the radioactive strontium-yttrium system by electrodeposition. Bunseki Kagaku 1958, 7, 243-6.
59. Boyd, G.E.; Larson, Q.V.; Motta, E.E. Isolation of milligram quantities of long-lived technetium from neutron irradiated molybdenum. J. Am. Chem. Soc., 1960, 82, 809-15.
60. Radioiotope production and radiation technology. IAEA Annual Report 2009. P.53. http://www.iaea.org/About/Policy/GC/GC54/GC54Documents/English/gc54-4_en.pdf
61. Hradil, G. Electroplating solution containing organic acid complexing agent. U.S. Patent 2004/0149587, August 5, 2004.
62. st Ed.; Marcel Dekker Inc.: New York, 1969.
63. nd Ed.; Wiley-VCH: New York, 2009.
64. Buzzeo, M.C.; Hardacre, C.; Compton, R.G. Extended electrochemical windows made accessible by room temperature ionic liquids/organic solvents electrolyte systems. ChemPhysChem, 2006, 7, 176-180.
65. Reischl, G.; Rosch, F.; Machulla, H.J. Electrochemical separation and purification of yttrium-86. Radiochim. Acta, 2002, 90, 225-228.
66. oC. In: Electrochemistry: Electrodeposition of metals and alloys. Achievements in Science: Chemistry Series Khomutov, N.E., Ed. Referativnyi Zhurnal Khimiya, Moscow, 1969; pp. 2-27.
67. Goldenberg, D.M. The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy. Crit. Rev. Oncol. Hematol., 2001, 39,195-201.
68. Grillo-Lopez, A.J. Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma. Expert Rev. Anticancer Ther., 2002, 2, 485-93.
69. Davies, A.J. Radioimmunotherapy for B-cell lymphoma: Y-90 ibritumomab tiuxetan and I-131 tositumomab. Oncogene 2007, 26, 3614-3628.
70. Witzig, T.E.; Molina, A.; Gordon, L.I.; Emmanouilides, C.; Schilder, R.J.; Flinn, I.W.; Darif, M.; Macklis, R.; Vo, K.; Wiseman, G.A. Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan. Cancer, 2007, 109, 1804-1810.
71. Paganelli, G.; Bartolomei, M.; Grana, C.; Ferrari, M.; Rocca, P.; Chinol, M. Radioimmunotherapy of brain tumour. Neurol. Res. 2006, 28, 518-522.
72. 90Y-DOTATOC. J. Nucl. Med., 2006, 47, 105-112.
73. Breeman, W.A.P.; Kwekkeboom, D.J.; de Blois, E.; de Jong, M.; Visser, T.J.; Krenning, E.P. Radiolabelled regulatory peptides for imaging and therapy. Anticancer Agents Med. Chem., 2007, 7, 345-347.
74. Kwekkeboom, D.J.; Mueller-Brand, J.; Paganelli, G.; Anthony, L.B.; Pauwels, S.; Kvols, L.K.; O'Dorisio, T.M.; Valkema, R.; Bodei, L.; Chinol, M.; Maecke, H.R.; Krenning, E.P. Overview of results of peptide receptor radionuclide therapy with three radiolabelled somatostatin analogs. J. Nucl. Med., 2005, 46, 62S-66S.
75. Gulec, S.A.; Mesoloras, G.; Dezarn, W.A.; McNeillie, P.; Kennedy, A.S. Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio. J. Transl. Med., 2007, 5, 15.
76. Wong, C.-Y.O.; Savin, M.; Sherpa, K.M.; Qing, F.; Campbell, J.; Gates, V.L.; Lewandowski, R.J.; Cheng, V.; Thie, J.; Fink-Bennett, D.; Nagle, C.; Salem, R. Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma. Cancer Biother. Radiopharm. 2006, 21, 305-313.
77. th ed.; John Wiley and Sons Inc.: New York, 1996.
78. 188Re generators. IAEA Technical Report Series No. 470, International Atomic Energy Agency, Vienna, 2009.
79. 90Y radioisotope generator. Int. J. Appl. Radiat. Isot., 1978, 29, 91-96.
80. Chinol, M.; Hnatowich, D.J. Generator-produced Yttrium-90 for radioimmunotherapy. J. Nucl. Med., 1987, 28, 1465-1470.
81. 188W. http://wwwpub. iaea.org/MTCD/publications/PubDetails.asp?pubId=8268. IAEA, 2010, 49-78.
82. Maximum permissible body burden and maximum permissible concentrations of radionuclides in air and water for occupational exposure. National Bureau of Standards Handbook. 69, U.S. Department of Commerce, AFP 160-67; 1959, p. 38.
83. Salutsky, M.L.; Kirby, H.W. Preparation and half-life of carrierfree yttrium-90. Anal Chem., 1955, 27, 567-569.
84. Wike, J.S.; Guyer, C.E.; Ramey, D.W.; Phillips, B.P. Chemistry for commercial scale production of yttrium-90 for medical research. Appl. Radiat. Isot., 1990, 41, 861-865.
85. Lee, T.W.; Ting, G. Study on the separation of carrier free Yttrium-90 from Sr-90. Isotopenpraxis, 1991, 27, 269-273.
86. Dietz, L.M.; Horwitz, E.P. Improved chemistry for production of yttrium-90 for medical applications. Appl. Radiat. Isot. 1992, 43, 1093-1101.
87. Hsieh, B.T.; Ting, G.; Hsieh, H.T.; Shen, L.H. Preparation of carrier-free yttrium-90 for medical applications by solvent extraction chromatography. Appl. Radiat. Isot., 1993, 44, 1473-1480.
88. 90Y generator using zirconium antimonate. Appl. Radiat. Isot., 1994, 45, 415-417.
89. 90Y by ion-exchange chromatography using an organic resin and a chelating agent. Nucl. Med. Biol., 2010, 37, 935-942.
90. 90Sr by SLM technique using D2EHPA in Ndodecane as carrier. Sep. Sci. Technol., 2010, 45, 554-561.
91. 90Y for clinical use. Radiochim. Acta, 2009, 97, 739-746.
92. 90Y. Radiochemistry, 2009, 51, 507-509.
93. 90Y separation by using a functionalized-silica. Appl. Radiat. Isot., 2009, 67, 1332-1335.
94. 90Y pair with cerium (IV) iodotungstate cation exchanger. Appl. Radiat. Isot., 2009, 67, 530-534.
95. 90Y using KSM-17 and CMPO as carriers. Sep. Sci. Technol., 2007, 42, 1107-1121.
96. Bray, L.A.; Wester, D.W. Method of separation of yttrium-90 from strontium-90. US Patent 5, 512, 256, April 30, 1996.
97. Bray, L.A. Method for separating and purifying Yttrium-90 from Strontium-90. WO/2006/025975. World Intellectual Property Organization, 2006.
98. 90Sr in multi-curie quantities. WO 01/80251. World Intellectual Property Organization, 2001.
99. Betenekov, N.D.; Sharygin, L.M.; Brown, R.W. Sr-90/Y-90 radionuclide generator for production of high quality Y-90 solution. WO/2006/046966. World Intellectual Property Organization, 2006.
100. 86Y using a small biomedical cyclotron. Nucl. Med. Biol. 2005, 32, 891-897.
101. 90Y generator. Radiochim. Acta, 2001, 89, 413-417.
102. 90Y for clinical use. Anal. Chem. 2008, 80, 801-807.
103. Knapp Jr., F.F. Rhenium-188-a generator-derived radioisotope for cancer therapy. Cancer Biother. Radiopharm., 1998, 13, 337-349.
104. Abram, U.; Alberto, R. Technetium and Rhenium-Coordination chemistry and nuclear medical applications. J. Braz. Chem. Soc., 2006, 17, 1486-1500.
105. Savio, E.; Gaudiano, J.; Robles, A.M.; Balter, H.; Paolino, A.; López, A.; Hermida, J.C.; De Marco, E.; Martinez, G.; Osinaga, E.; Knapp Jr., F.F. Re-HEDP: pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose. BMC Nucl. Med. 2001, 1, 2-10.
106. 188Re(V) DMSA distribution in patients with prostate cancer metastatic to bone. Eur. J. Nucl. Med., 2000, 27, 1405-1409.
107. Liepe, K.; Hlisecs, R.; Kropp, J.; Gruning, T.; Runge, R.; Koch, R.; Knapp Jr., F.F.; Franke, W.G. Rhenium-188-HEDP in palliative treatment of bone metastases. Cancer Biother. Radiopharm., 2000, 15, 261-265.
108. Palmedo, H.; Guhlke, S.; Bender, H.; Sartor, J.; Schoeneich, G.; Risse, J.; Grunwald, F.; Knapp, F.F.; Biersack, H.J. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. Eur. J. Nucl. Med., 2000, 27,123-130.
109. Knapp Jr., F.F.; Spencer, R.H.; Kropp, J. Intravascular radiation therapy with radioactive filled balloons for inhibition of restonosis after angioplasty: A new opportunity for nuclear medicine?. J. Nucl. Med., 2001, 42, 1384-1387.
110. Weinberger, J.; Giedd, K.N.; Simon, A.D.; Marboe, C.; Knapp Jr., F.F.; Trichter, F.; Amols, H. Radioactive beta-emitting solutionfilled balloon treatment prevents porcine coronary restonosis. Cardiovasc. Rad. Med., 1999, 1, 252-256.
111. 99mTc complexes of 2-(4-aminophenyl) benzothiazole as potential breast cancer radiopharmaceuticals. J. Med. Chem., 2010, 53, 4633-4641.
112. 188Re-DTPA-Deoxyglucose as a potential cancer radiopharmaceutical. Am. J. Roentgenol., 2010, 194, 761-765.
113. Hafeli, U.O.; Warburton, M.C.; Landau, U. Electrodeposition of radioactive rhenium onto stents to prevent restonosis. Biomaterials, 1998, 19, 925-933.
114. 188Re Generators. Appl. Radiat. Isot., 1994, 45, 1123-1128.
115. Ponsard, B.; Hiltunen, J.; Ruiz, H.V.; Beets, A.L.; Mirzadeh, S.; Knapp Jr., F.F. The tungsten-188/rhenium-188 generator: Effective coordination of tungsten-188 production between HFIR and BR2 reactors. J. Radioanal. Nucl. Chem. 2003, 257, 169-174.
116. 188Re generator. J. Nucl. Med., 2000, 41, 1271-1278.
117. Jeong, J.M.; Knapp Jr., F.F. Use of the Oak Ridge National Laboratory Tungsten-188/Rhenium-188 generator for preparation of the Rhenium-188 HDD/Lipiodol complex for trans-arterial liver cancer therapy. Semin. Nucl. Med., 2008, 38, S19-S29.
118. 188Re generator. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34, S210.
119. 188Re generator for biomedical applications. Radiochim. Acta, 1994, 65, 39-46.
120. Knapp Jr., F.F.; Lisic, E.C.; Mirzadeh, S. Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system. US patent 5, 275, 802, February 16, 1993.
121. 188Re generator. Appl. Radiat. Isot., 2009, 67, 234-239.
122. 188Re-perrrhenate. Radiochim. Acta, 2006, 94, 107-111.
123. 188Re aqueous solutions of high and reproducible activity concentrations. Appl. Radiat. Isot., 2005, 63, 299-304.
124. 4- by a single, compact, anion exchange cartridge. Nucl. Med. Commun., 2004, 25, 957-962.
125. International Atomic Energy Agency. Operation Research Reactors in the World [database] Available at: http://wwwnaweb. iaea.org/napc/physics/research_reactors/database/RR%20Da ta%20Base/datasets/foreword_home.html. Accessed on March 10, 2012.
126. Mickhailov, N.J.; Melnikova, M.M.; Lukashina, N.D. Electrodeposition of rare earth metals and alloys. In: Electrochemistry: Electrodeposition of metals and alloys-Achievements in Science: Chemistry Series. Khomutov N.E., Ed. Referativnyi Zhurnal Khimiya, Moscow; 1969; p. 175.
127. Hahn, B.P.; May, R.A.; Stevenson, K.J. Electrochemical deposition and characterization of mixed valent rhenium oxide films prepared from a perrhenate solution. Langmuir, 2007, 23, 10837-10845.
128. Vajo, J.J.; Aikens, D.A.; Ashley, L.; Poeltl, D.E.; Bailey, R.A.; Clark, H.M.; Bunce, S.C. Facile electroreduction of perrhenate in weakly acidic citrate and oxalate media. Inorg. Chem., 1981, 20, 3328-3333.
129. British Pharmacopoeia Commission, British Pharmacopoeia, 2008, The Stationery Office, Norwich, U.K. (www.pharmacopoeia.org.uk)
130. Richards, P.; Tucker, W.D.; Srivastava, S.C. Technetium-99m: An historical perspective. Int. J. Appl. Radiat. Isot. 1982, 33, 793-799.
131. Banerjee, S.; Pillai, M.R.A.; Ramamoorthy, N. Evolution of Tc-99m in diagnostic radiopharmaceuticals. In Seminars in Nuclear Medicine-Radiochemistry Update. 2001,31, 260-277.
132. 99mTc generator shortage: Free web-based software. J. Nucl. Med., 2010, 51, 14N-15N.
133. Gould P. Medical isotope shortage reaches crisis level. Nature 2009; 460: 312-313.
134. Perkins, A.C.; Vivian, G. Molybdenum supplies and nuclear medicine services. Nucl. Med. Commun., 2009, 30, 657-659.
135. Webster, P. North America's medical isotope crisis. Lancet, 2009, 374, 103.
136. 99Mo shortage in nuclear medicine: crisis or challenge? J. Label. Compds. Radiopharm., 2010, 53, 167-168.
137. Gould, P. Medical isotopes: time to secure supplies? Lancet Oncol., 2008, 9, 1027.
138. Ballinger, J.R. Short-and long-term responses to molybdenum-99 shortages in nuclear medicine. Brit. J. Radiol., 2010, 83, 899-901.
139. 99mTc shortage: Are options being overlooked? J. Nucl. Med., 2011, 52, 15N-28N.
140. Pillai, M.R.A.; Knapp Jr., F.F. Molybdenum-99 Production from Reactor Irradiation of Molybdenum Targets: A Viable Strategy for enhanced availability of technetium-99m. Q. J. Nucl. Med. Mol. Imaging (In Press).
141. Ali, S.A.; Ache, H.J. Production techniques of fission molybdenum-99. Radiochim. Acta, 1987, 41, 65-72.
142. Masson, M.; Lecomte, M.; Masslennikov, A.; Peretroukhine, V. Method of separating technetium from a nitric acid solution. U.S. Patent No. 6179981, January 30, 2001.
143. Mirzadeh, S; Knapp Jr., F.F. Spontaneous electrochemical separation of carrier-free copper-64 and copper-67 from zinc targets. Radiochim. Acta, 1992, 57, 193.
144. 67Cu. Appl. Radiat. Isot., 1986, 37, 29-36.